Kojic Acid Concentration in Brightening Serums
Practical guidance on kojic acid levels in brightening serums and where hotlist restrictions and drug-claim lines can trip up a formula.
Kojic acid shows up in more brightening serum formulas than almost any other actives category, and it's also one of the ingredients makers underestimate on the compliance side. It's not that it's exotic. It's that the concentration you pick interacts with both restricted-substance rules and how far your marketing language can go before the product stops being a cosmetic at all.
What kojic acid actually does in a formula
Kojic acid is a byproduct of fermenting certain fungi, prized for inhibiting the enzyme involved in melanin production. That's what gives it a reputation for evening out hyperpigmentation and dark spots. Formulators typically work with it in the low single-digit percentage range in leave-on products like serums, often blended alongside other brightening actives such as alpha arbutin, niacinamide, or vitamin C derivatives to reduce the amount of any one ingredient needed.
That blending approach isn't just a formulation nicety. It matters for compliance because concentration limits and restrictions in different markets are set per ingredient, not per finished-product outcome. Stacking a lower level of kojic acid with complementary actives can get you a visibly effective serum without pushing any single ingredient toward its ceiling.
Where restrictions come from
Cosmetic ingredient restrictions vary by market, and kojic acid is one of those substances where you genuinely need to check the current hotlist or restricted list for wherever you're selling rather than relying on a number you saw in a forum post last year. In Canada, for example, the Cosmetic Ingredient Hotlist is the authoritative source for prohibited and restricted substances, and it gets updated. A concentration that was fine two years ago is not guaranteed to still be fine today.
The practical habit worth building:
- Confirm the ingredient's status on the hotlist or restricted list for your target market before you lock a formula.
- Note whether the restriction is a hard ceiling, a conditional limit tied to product type (leave-on versus rinse-off), or a labeling requirement rather than a use restriction.
- Re-check before every reformulation or resale into a new market, since limits differ market to market and can change over time.
The claims problem is bigger than the concentration problem
Here's where a lot of brightening serums quietly step outside cosmetic territory. "Brightens the look of dark spots" is a cosmetic claim. "Treats hyperpigmentation" or "reduces melasma" starts to sound like a drug claim, because it implies a therapeutic effect on a medical condition rather than a cosmetic, temporary appearance change. The ingredient concentration doesn't change based on your marketing copy, but your regulatory category can.
This is the same logic that pulls a soap out of "true soap" treatment the moment it makes a cosmetic claim like moisturizing, and it's the same logic that turns a cosmetic into a drug filing the moment the claim promises to treat or cure something. A kojic acid serum sold as a cosmetic needs its language to stay in appearance-and-look territory. Once you start promising treatment of a named skin condition, you're likely looking at drug-level substantiation requirements instead of a straightforward cosmetic notification.
A rough reference table
| Consideration | What to check | Why it matters |
|---|---|---|
| INCI concentration | Current hotlist or restricted list for your market | Limits can be market-specific and change over time |
| Product type | Leave-on vs rinse-off | Some restrictions differentiate by exposure type |
| Claim language | "Brightens the look of" vs "treats" or "cures" | Determines cosmetic vs drug classification |
| Stability | Kojic acid can be less stable in some formulas over time | Affects real-world concentration at shelf life, not just at batch |
Building this into your filing process
When you're ready to notify a brightening serum, whether that's a Cosmetic Notification Form in Canada or an equivalent filing elsewhere, the ingredient concentration you declare should reflect what's actually in the finished product, not a rounded estimate. If kojic acid is part of a supplier blend rather than added neat, remember to multiply the blend's use level by the component's share of that blend to get the real percentage you're reporting.
This is one of the areas where Cosmetic Comply's ingredient matching is genuinely useful, since it screens each ingredient against the market's restricted list with a confidence score and flags anything worth a second look before a real reviewer signs off. For a brightening serum where the concentration and the claim both need to line up, that extra check is worth having before you file.
Send your ingredients and we take it from here
A short intake form is all it takes to start. Every ingredient gets checked against your market's prohibited and restricted lists, then we file your notification and hand you a number you can track.
Start a filingKeep reading
A Concentration Checklist to Run Before Submitting a CNF
Before you hit submit on a Cosmetic Notification Form, run every restricted ingredient through this concentration check to avoid a rejected filing.
Does Willow Bark Extract Count Toward Salicylic Acid Limits
Willow bark extract carries natural salicylates, and that raises a real question about whether it counts toward your salicylic acid concentration limit.
Salicylic Acid in a Shampoo Versus a Leave-On Serum
Why the same salicylic acid percentage can be fine in a scalp shampoo but risky in a leave-on face serum, and what that means for your filing.
Breaking Down a Broad-Spectrum Preservative Blend by Percent
How to split a multi-component preservative blend into its regulated parts for a CNF, with the actual math shown.